Covered recipient · General Payments record
MIN WANG
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2023
$443.05
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $178.31 | 8 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $82.91 | 4 |
| Janssen Pharmaceuticals, Inc | $53.72 | 2 |
| Alkermes, Inc. | $25.44 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $25.44 | 05/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022937903 | CMS |
| Janssen Pharmaceuticals, Inc | $36.35 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987835941 | CMS |
| Janssen Pharmaceuticals, Inc | $17.37 | 09/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987835933 | CMS |
| Neurocrine Biosciences, Inc. | $21.74 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052293259 | CMS |
| Neurocrine Biosciences, Inc. | $18.22 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052293361 | CMS |
| Neurocrine Biosciences, Inc. | $21.56 | 07/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052293413 | CMS |
| Neurocrine Biosciences, Inc. | $21.39 | 09/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052293441 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.24 | 07/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056976593 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.